title: Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl.
abstract: We present a case of toxic epidermal necrolysis (TEN) triggered by clobazam in a 13-year-old girl who was subsequently treated with intravenous immunoglobulin. In December 2013 the U.S. Food and Drug Administration released a warning that clobazam might cause "serious skin reactions" such as Stevens-Johnson syndrome or TEN and approved label changes.
authors.affiliation: Department of Pediatrics, Kaiser Permanente, Oakland Medical Center, Oakland, California.
authors.forename: Chuong D
authors.initials: CD
authors.lastname: Dang
authors.affiliation: Department of Dermatology, Kaiser Permanente, Oakland Medical Center, Oakland, California.
authors.forename: Linda
authors.initials: L
authors.lastname: Beets-Shay
authors.affiliation: Department of Dermatology, Kaiser Permanente, Oakland Medical Center, Oakland, California.
authors.forename: Estelle C
authors.initials: EC
authors.lastname: Kahn
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D000078306:Clobazam; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000628:therapy
chemical_list: D000927:Anticonvulsants; D016756:Immunoglobulins, Intravenous; D001569:Benzodiazepines; D000078306:Clobazam